H. Cortez‐Pinto
Epidemiology · 2010–2023
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 153 citations into it
Whom H. Cortez‐Pinto trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Giulio Marchesini (in Epidemiology)
Papers from H. Cortez‐Pinto's perspective
Ordered by how strongly the researchers H. Cortez‐Pinto trusts endorse each paper. Same corpus, a different order for every researcher.
- Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study (Hepatology)
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Hepatology)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
- Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
- 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
- Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity (Hepatology)
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (Hepatology)
- Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. (Journal of Clinical Endocrinology and Metabolism)
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
- Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. (Diabetes)
Their papers
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature (2023) — 2,276 citations
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature. (2023) — 2,621 citations
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
- A new definition for metabolic associated fatty liver disease: an international expert consensus statement. (2020) — 3,051 citations
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. (2019) — 1,024 citations
- Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. (2018) — 601 citations
- EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. (2018) — 757 citations
- A position statement on NAFLD/NASH based on the EASL 2009 special conference. (2010) — 1,090 citations